Tag Archives: FDA

Are antidepressants safe for kids?

Patients with depression were eleven times more likely to experience significant benefit from antidepressant medication than to experience medication-related suicidal thinking or behavior, patients with OCD were thirty-four times more likely to experience benefit and patients with non-OCD anxiety were thirty-six times more likely to experience benefit. Continue reading

Posted in Anxiety Disorders, Controversies, Depression, Mental Health | Tagged , , , , , , , , , | 5 Comments

The FDA finally takes action on a problem with generic ADHD medication

Based on an analysis of data, FDA has concerns about whether or not two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. Continue reading

Posted in ADHD, Controversies, Mental Health | Tagged , , , , , , , , , , | Leave a comment

Hot Topics: Are Antidepressant Medications Safe For Kids?

Few topics in child and adolescent mental health have generated as much controversy over the last decade as the debate about the safety of antidepressant medication given to kids. In 2004, the FDA issued a “black box” warning claiming that antidepressant use in children and teenagers is associated with increases in suicidal thinking and behavior, which was expanded in 2007 to include adults between the ages of 18 and 24. In my opinion, the larger controversy about antidepressant use in children and teens is not “are they safe?” but “do they work?” and if they work, what do they work for? Some of those questions were addressed here.
Continue reading

Posted in Anxiety Disorders, Mental Health | Tagged , , , , , , , , | 2 Comments

Be Not Anxious…Is Medication Safe for Kids With Anxiety?

One of the greatest ongoing controversies in the fields of child psychiatry and pediatrics is the question of how safe SSRIs are in children, teens and young adults. The safety issue of greatest concern involves reported risks of SSRIs increasing suicidal thoughts during the first 30-60 days of treatment in persons under the age of 25.
Continue reading

Posted in Anxiety Disorders, Controversies | Tagged , , , , , , | Leave a comment